This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:physicians:concerns [02.09.2019] – [Concerns about lack of clinical evidence] sallieq | home:physicians:concerns [05.09.2019] – [Numerical improvements update] sallieq | ||
---|---|---|---|
Line 16: | Line 16: | ||
For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | ||
* evidence for the efficacy of MP versus other available treatment options(({{pubmed> | * evidence for the efficacy of MP versus other available treatment options(({{pubmed> | ||
- | * patients' | ||
* more recent material on patient response, see below update | * more recent material on patient response, see below update | ||
+ | * patients' | ||
* additional benefits of Olmesartan [[https:// | * additional benefits of Olmesartan [[https:// | ||
* orphan drug status – Autoimmunity Research Foundation has won [[home: | * orphan drug status – Autoimmunity Research Foundation has won [[home: | ||
Line 25: | Line 25: | ||
< | < | ||
- | ===== Numerical improvements update | + | ===== Recorded success rates |
< | < |